Definium Therapeutics, Inc. Earnings Per Share (Basic)
Definium Therapeutics, Inc. (DFTX) reported Earnings Per Share (Basic) of -$1.44 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Definium Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.44.
- Definium Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.71.
- Definium Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.50.
- Definium Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.78.
- Definium Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$2.06.
- Definium Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$1.54.
- Definium Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$2.44.
- Definium Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.84.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.44 10-Q · filed 2026-08-06 | -$2.15 10-Q · filed 2026-08-06 | -$2.68 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.48 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$0.71 10-Q · filed 2026-05-07 | -$1.22 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.98 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$2.49 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.06 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$0.78 10-Q · filed 2025-11-06 | -$1.28 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.56 10-Q · filed 2025-11-06 | -$1.98 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.50 10-Q · filed 2026-08-06 | -$0.78 10-Q · filed 2026-08-06 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.38 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-03-31 | -$0.27 10-Q · filed 2026-05-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-05-07 | ||
| 2024-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.54 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$0.18 10-Q · filed 2025-11-06 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.12 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$0.08 10-Q · filed 2025-07-31 | -$1.01 10-Q · filed 2025-07-31 | ||||
| 2024-03-31 | -$1.14 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | -$2.44 10-K · filed 2025-03-06 | |||||
| 2023-09-30 | -$0.45 10-Q · filed 2024-11-07 | -$1.85 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | -$0.76 10-Q · filed 2024-08-13 | -$1.41 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | -$0.65 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | -$1.84 10-K · filed 2024-02-28 | |||||
| 2022-09-30 | -$0.56 10-Q · filed 2023-11-02 | -$1.82 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | -$0.60 10-Q · filed 2023-08-03 | -$0.04 10-Q · filed 2022-08-11 | -$1.26 10-Q · filed 2023-08-03 | -$0.08 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | -$0.66 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | -$3.40 10-K · filed 2023-03-09 | |||||
| 2021-09-30 | -$0.61 10-Q · filed 2022-11-10 | -$2.81 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$0.11 10-Q · filed 2022-08-11 | -$0.15 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |